SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-016498
Filing Date
2024-02-23
Accepted
2024-02-23 16:01:29
Documents
3
Period of Report
2024-02-23

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0200558-6k_clearmind.htm 6-K 11785
2 PRESS RELEASE TITLED: "CLEARMIND MEDICINE RECEIVES APPROVAL TO COMMENCE ITS PHAS ea0200558ex99-1_clearmind.htm EX-99.1 12268
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4388
  Complete submission text file 0001213900-24-016498.txt   31311
Mailing Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5
Business Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5 972-54-5704749
Clearmind Medicine Inc. (Filer) CIK: 0001892500 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 6-K | Act: 34 | File No.: 001-41557 | Film No.: 24671023
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)